{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:33Z","timestamp":1791308853015,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019501","name":"Universidad Peruana Cayetano Heredia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010747","name":"National Council of Science Technology and Technology Innovation","doi-asserted-by":"publisher","award":["PE501082183-2023"],"award-info":[{"award-number":["PE501082183-2023"]}],"id":[{"id":"10.13039\/501100010747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jctube.2026.100626","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:22:00Z","timestamp":1782231720000},"page":"100626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study"],"prefix":"10.1016","volume":"44","author":[{"given":"Catherine","family":"Sulca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Piamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Quispe-Ricalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Palma","family":"Albornoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Tuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2026.100626_bb0005","series-title":"Global tuberculosis report 2024 [internet]","author":"World Health Organization","year":"2024"},{"issue":"3","key":"10.1016\/j.jctube.2026.100626_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2012.04614.x","article-title":"Is interferon-gamma the right marker for bacille Calmette\u2013Gu\u00e9rin-induced immune protection? The missing link in our understanding of tuberculosis immunology","volume":"169","author":"Abebe","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2386030","article-title":"Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review","volume":"56","author":"Leo","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.jctube.2026.100626_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","article-title":"Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis","volume":"53","author":"Achkar","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.jctube.2026.100626_bb0025","article-title":"A broader evaluation of vaccine-induced T cell immunity against tuberculosis","volume":"18","author":"Ogongo","year":"2024","journal-title":"Frontiers in Tuberculosis"},{"issue":"1","key":"10.1016\/j.jctube.2026.100626_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.jctube.2026.100626_bb0035","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiy258","article-title":"Cytophilic antibodies against key Plasmodium falciparum blood stage antigens contribute to protection against clinical malaria in a high transmission region of eastern India","volume":"218","author":"Kana","year":"2018","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.jctube.2026.100626_bb0040","article-title":"Sustained antibody-dependent NK cell functions in mild COVID-19 outpatients during convalescence","volume":"7","author":"Fuentes-Villalobos","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"Dilillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jctube.2026.100626_bb0050","article-title":"Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jctube.2026.100626_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583820","article-title":"Polyfunctional fc dependent activity of antibodies to native trimeric envelope in HIV elite controllers","volume":"11","author":"Kant","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jctube.2026.100626_bb0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jctube.2026.100626_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2016.08.001","article-title":"Antibodies and tuberculosis","volume":"101","author":"Jacobs","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jctube.2026.100626_bb0070","article-title":"Antibodies as key mediators of protection against Mycobacterium tuberculosis","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jctube.2026.100626_bb0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/IAI.69.3.1755-1765.2001","article-title":"Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms","volume":"69","author":"Brill","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.jctube.2026.100626_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2018.00257","article-title":"Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease","volume":"19","author":"Garand","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jctube.2026.100626_bb0085","article-title":"Antibody subclass and glycosylation shift following effective TB treatment","volume":"5","author":"Grace","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jctube.2026.100626_bb0090","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.4049\/jimmunol.1600544","article-title":"B cell responses associated with vaccine-induced delayed SIVmac251 acquisition in female rhesus macaques","volume":"197","author":"Mohanram","year":"2016","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.jctube.2026.100626_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jim.2005.09.018","article-title":"A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity","volume":"308","author":"G\u00f3mez-Rom\u00e1n","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jctube.2026.100626_bb0100","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/pathogens12101241","article-title":"Natural killer repertoire restoration in TB\/HIV co-infected individuals experienced an immune reconstitution syndrome (CAMELIA trial, ANRS 12153)","volume":"12","author":"Pean","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.jctube.2026.100626_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","article-title":"Role of IgG3 in infectious diseases","volume":"40","author":"Damelang","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0110","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol Rev"},{"issue":"6","key":"10.1016\/j.jctube.2026.100626_bb0115","article-title":"Evaluation of immunogenicity and protective efficacy elicited by Mycobacterium bovis BCG overexpressing Ag85A protein against Mycobacterium tuberculosis aerosol infection","volume":"28","author":"Xu","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jctube.2026.100626_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6673250","article-title":"ESAT-6 and Ag85A synthetic peptides as candidates for an immunodiagnostic test in children with a clinical suspicion of tuberculosis","volume":"2021","author":"Araujo","year":"2021","journal-title":"Dis Markers"},{"key":"10.1016\/j.jctube.2026.100626_bb0125","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2017.05.012","article-title":"Antigen availability shapes T cell differentiation and function during tuberculosis","volume":"21","author":"Moguche","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jctube.2026.100626_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5517856","article-title":"Phenotype of peripheral NK cells in latent, active, and meningeal tuberculosis","author":"Chore\u00f1o-Parra","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jctube.2026.100626_bb0135","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jctube.2026.100626_bb0140","doi-asserted-by":"crossref","first-page":"e01007","DOI":"10.1128\/mBio.01007-14","article-title":"Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus Sepsis in mice","volume":"5","author":"Varshney","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.jctube.2026.100626_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005687","article-title":"Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment","volume":"12","author":"Joosten","year":"2016","journal-title":"PLoS Pathog"},{"issue":"16","key":"10.1016\/j.jctube.2026.100626_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells14161252","article-title":"Donor variability and seeding density shape NK-cell proliferation and surface receptor expression: insights from an integrated phenotypic and genetic analysis","volume":"14","author":"Kusch","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jctube.2026.100626_bb0155","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1073\/pnas.1621360114","article-title":"Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring","volume":"114","author":"Liu","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jctube.2026.100626_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.856906","article-title":"Defining discriminatory antibody fingerprints in active and latent tuberculosis","volume":"13","author":"Nziza","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0165","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and Allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729186","article-title":"A Mycobacterium tuberculosis specific IgG3 signature of recurrent tuberculosis","volume":"12","author":"Fischinger","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jctube.2026.100626_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jctube.2026.100626_bib186","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imm.13531","article-title":"The kinetics of IgG subclasses and contributions to neutralizing activity against SARS\u2010CoV\u20102 wild\u2010type strain and variants in healthy adults immunized with inactivated vaccine","volume":"167","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jctube.2026.100626_bib187","doi-asserted-by":"crossref","first-page":"101978","DOI":"10.1016\/j.tube.2020.101978","article-title":"Mycobacterium tuberculosis-specific plasmablast levels are differentially modulated in tuberculosis infection and disease","volume":"124","author":"Gindeh","year":"2020","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.jctube.2026.100626_bib188","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.13115","article-title":"COVID\u201019 and plasma cells: Is there long\u2010lived protection?","volume":"309","author":"Nguyen","year":"2022","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.jctube.2026.100626_bib189","doi-asserted-by":"crossref","unstructured":"Moura AD, da Costa HHM, Correa VA, de S Lima AK, Lindoso JAL, De Gaspari E, Hong MA, Cunha-Junior JP, Prudencio CR. Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients. Scientific Reports 2021; 11 (1): 17642. doi: 10.1038\/s41598-021-95045-z.","DOI":"10.1038\/s41598-021-95045-z"},{"key":"10.1016\/j.jctube.2026.100626_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.jctube.2026.100626_bib191","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.jctube.2026.100626_bib192","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s43587-025-00910-5","article-title":"Immune surveillance of senescent cells in aging and disease","volume":"5","author":"Majewska","year":"2025","journal-title":"Nat Aging"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579426000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579426000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:55:11Z","timestamp":1785772511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579426000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S2405579426000483"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2026.100626","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2026.100626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100626"}}